These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23060423)

  • 21. New drugs targeting the cardiac ultra-rapid delayed-rectifier current (I Kur): rationale, pharmacology and evidence for potential therapeutic value.
    Ford JW; Milnes JT
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):105-20. PubMed ID: 18670369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of selective IKr channel blockade by E-4031 on ventricular electro-mechanical relationship in the halothane-anesthetized dogs.
    Izumi-Nakaseko H; Nakamura Y; Cao X; Ohara H; Yamazaki Y; Ueda N; Ando K; Sugiyama A
    Eur J Pharmacol; 2014 Oct; 740():263-70. PubMed ID: 25038475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sick sinus syndrome with and without atrial fibrillation: atrial refractoriness and conduction characteristics.
    De Sisti A; Leclercq JF; Fiorello P; Di Lorenzo M; Manot S; Halimi F; Attuel P
    Cardiologia; 1999 Apr; 44(4):361-7. PubMed ID: 10371788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of delayed rectifier K+ current by dofetilide and E-4031 differentially affects electrical cardiac responses to vagus stimulation in anesthetized dogs.
    Imamura H; Furukawa Y; Kasama M; Hoyano Y; Yonezawa T; Chiba S
    Jpn J Pharmacol; 1998 Jan; 76(1):31-7. PubMed ID: 9517402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico study on the effects of IKur block kinetics on prolongation of human action potential after atrial fibrillation-induced electrical remodeling.
    Tsujimae K; Murakami S; Kurachi Y
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H793-800. PubMed ID: 18055524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifibrillatory properties of mivacurium in a canine model of atrial fibrillation.
    Patterson E; Lu Z; Lin J; Scherlag BJ; Po SS; Coscia D; Lazzara R
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):293-303. PubMed ID: 18356695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model.
    Oliveira M; Silva MN; Geraldes V; Postolache G; Xavier R; Laranjo S; Rocha I; Ferreira R; Silva-Carvalho L
    Rev Port Cardiol; 2010 Mar; 29(3):375-89. PubMed ID: 20635563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both.
    Caballero R; de la Fuente MG; Gómez R; Barana A; Amorós I; Dolz-Gaitón P; Osuna L; Almendral J; Atienza F; Fernández-Avilés F; Pita A; Rodríguez-Roda J; Pinto A; Tamargo J; Delpón E
    J Am Coll Cardiol; 2010 May; 55(21):2346-54. PubMed ID: 20488306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput analysis of drug binding interactions for the human cardiac channel, Kv1.5.
    Karczewski J; Kiss L; Kane SA; Koblan KS; Lynch RJ; Spencer RH
    Biochem Pharmacol; 2009 Jan; 77(2):177-85. PubMed ID: 18955031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute vagal modulation of electrophysiology of the atrial and pulmonary veins increases vulnerability to atrial fibrillation.
    Oliveira M; da Silva MN; Geraldes V; Xavier R; Laranjo S; Silva V; Postolache G; Ferreira R; Rocha I
    Exp Physiol; 2011 Feb; 96(2):125-33. PubMed ID: 20952490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rotor termination is critically dependent on kinetic properties of I kur inhibitors in an in silico model of chronic atrial fibrillation.
    Scholz EP; Carrillo-Bustamante P; Fischer F; Wilhelms M; Zitron E; Dössel O; Katus HA; Seemann G
    PLoS One; 2013; 8(12):e83179. PubMed ID: 24376659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NIP-141, a multiple ion channel blocker, terminates aconitine-induced atrial fibrillation and prevents the rapid pacing-induced atrial effective refractory period shortening in dogs.
    Hashimoto N; Yamashita T; Fujikura N; Tsuruzoe N
    Europace; 2007 Apr; 9(4):246-51. PubMed ID: 17350982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and evaluation of phenethylaminoheterocycles as K(v)1.5 inhibitors.
    Johnson JA; Xu N; Jeon Y; Finlay HJ; Kover A; Conder ML; Sun H; Li D; Levesque P; Hsueh MM; Harper TW; Wexler RR; Lloyd J
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3018-22. PubMed ID: 24881565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
    Lagrutta A; Wang J; Fermini B; Salata JJ
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kv1.5 blockers for the treatment of atrial fibrillation: approaches to optimization of potency and selectivity and translation to in vivo pharmacology.
    Bilodeau MT; Trotter BW
    Curr Top Med Chem; 2009; 9(5):436-51. PubMed ID: 19519460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based virtual screening and electrophysiological evaluation of new chemotypes of K(v)1.5 channel blockers.
    Yang Q; Fedida D; Xu H; Wang B; Du L; Wang X; Li M; You Q
    ChemMedChem; 2010 Aug; 5(8):1353-8. PubMed ID: 20540065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling the binding modes of Kv1.5 potassium channel and blockers.
    Yang Q; Du L; Wang X; Li M; You Q
    J Mol Graph Model; 2008 Sep; 27(2):178-87. PubMed ID: 18485768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzopyran sulfonamides as KV1.5 potassium channel blockers.
    Lloyd J; Atwal KS; Finlay HJ; Nyman M; Huynh T; Bhandaru R; Kover A; Schmidt J; Vaccaro W; Conder ML; Jenkins-West T; Levesque P
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3271-5. PubMed ID: 17462888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective Kv1.5 blockers: development of (R)-1-(methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a potential treatment for atrial arrhythmia.
    Blass BE; Fensome A; Trybulski E; Magolda R; Gardell SJ; Liu K; Samuel M; Feingold I; Huselton C; Jackson CM; Djandjighian L; Ho D; Hennan J; Janusz JM
    J Med Chem; 2009 Nov; 52(21):6531-4. PubMed ID: 19888755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin injection in epicardial autonomic ganglia temporarily suppresses vagally mediated atrial fibrillation.
    Oh S; Choi EK; Zhang Y; Mazgalev TN
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):560-5. PubMed ID: 21659633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.